First Trust Nasdaq Pharmaceuticals ETF (FTXH) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Asset Management Branche.
FTXH hat IPO-Datum 2016-09-22, gelistet an der NASDAQ Global Market, eine Marktkapitalisierung von $29.29M.
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
